.

Pharmaceutical Business Intelligence

  • Anticipate P&T budget requirements
  • Evaluate market entry opportunities
  • Find generic sources and suppliers
  • Predict branded drug patent expiration

► Plans and Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

DrugPatentWatch Database Preview

Details for Patent: 6,548,079

« Back to Dashboard
Patent 6,548,079 protects AVELOX IN SODIUM CHLORIDE 0.8% IN PLASTIC CONTAINER and is included in one NDA. There has been one Paragraph IV challenge on Avelox in Sodium Chloride 0.8% in plastic container. There are three tentative approvals for the compound protected by this patent. Additional details are available via the generic ingredient links below.

This patent has forty-five patent family members in thirty-seven countries.

Summary for Patent: 6,548,079

Title: Moxifloxacin formulation containing common salt
Abstract:The present invention relates to an aqueous formulation comprising moxifloxacin hydrochloride and sodium chloride, to the formulation for use as a medicament and to the use of the formulation for preparing a medicament for preventing or treating bacterial infections in humans or animals.
Inventor(s): Kuhn; Bernd (Koln, DE), Mahler; Hans-Friedrich (Koln, DE), Eisele; Michael (Bergisch Gladbach, DE)
Assignee: Bayer Aktiengesellschaft (Leverkusen, DE)
Application Number:10/049,095
Patent Claim Types:
see list of patent claims
Formulation; Compound; Use; Composition;
Patent Metrics:
Source: PatentQuant.com
Field: Medical technology
Back Citations: 12th percentile
Forward Citations: 0th percentile

Applicant Tradename Generic Name Dosage NDA Approval Date Type RLD Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use
Bayer Hlthcare
AVELOX IN SODIUM CHLORIDE 0.8% IN PLASTIC CONTAINER
moxifloxacin hydrochloride
SOLUTION;IV (INFUSION)021277-001Nov 30, 2001RXYes6,548,079► subscribeY METHOD OF COMBATING BACTERIA IN A PATIENT
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Foreign Priority and PCT Information for Patent: 6,548,079

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
Germany199 37 116Aug 06, 1999
PCT Information
PCT FiledJuly 25, 2000PCT Application Number:PCT/EP00/07098
PCT Publication Date:February 15, 2001PCT Publication Number: WO01/10465

International Patent Family for Patent: 6,548,079

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Argentina025001► subscribe
Austria270104► subscribe
Australia6159600► subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

For more information try a trial or see the database preview and plans and pricing

How are People Using DrugPatentWatch?

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

`abc